Allergan
728
0
3
597
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
12.6%
92 terminated/withdrawn out of 728 trials
86.6%
+0.1% vs industry average
42%
307 trials in Phase 3/4
81%
483 of 597 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (728)
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor
Role: collaborator
Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence
Role: collaborator
INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study
Role: collaborator
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
Role: collaborator
Intra Articular Injection of Botulinum Toxin Versus Corticoids in Gonarthrosis
Role: collaborator
A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
Role: lead
18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
Role: lead
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Role: lead
A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines
Role: lead
A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
Role: lead
Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment
Role: lead
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability
Role: collaborator
A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants
Role: lead
Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device
Role: collaborator
JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population
Role: lead
Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult Participants
Role: lead
HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation
Role: lead
Botox in the Healing of Surgical Wounds of the Neck
Role: collaborator
Keratometric Change After XEN, Trabeculectomy and Tube Shunts
Role: collaborator
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
Role: lead